House Calls, #1012, April 26, 2026: Tune in but don’t drop out

U.S. FDA plans an ultra-fast review of three psychedelic drugs for the treatment of severe mental illnesses such as treatment-resistant depression. PTSD, and alcohol use disorder.

Your Calls and Comments:

  • A 73 year old woman with osteopenia experienced joint pain with the use of a bisphosphonate medication, risedronate and had questions about the use of Jubbonti (denosumab) after her doctor recommended this option. We reviewed this medication and discussed the calculus behind risk vs benefit for her circumstance.
  • The use of creatine for an 80 year old man who swims for fitness.
  • A woman experiences jaw damage from osteonecrosis (bone death) after dental surgery. She was taking denosumab for osteoporosis. This is a potential side effect of the medication in this circumstance. She want to know what other options are available to her to treat her osteoporosis.
  • Muscle aches after thyroid gland removal (thyroidectomy). Why does this happen?

Playlist

1st segment

Intro:  Analyze – The Cranberries

Outro: Can’t Get It Out of My Head – ELO

2nd segment

Intro: Asylum – Supertramp

Outro: California Dreamin- The Mamas & The Papas

3rd segment

Intro: Comfortably Numb – Pink Floyd

Outro:  Beyond the Sea- Bobby Darin

4th segment

Intro:  Bitter Tears -INXS

Outro: Come Sail Away – Styx